BlackRock’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $916M | Buy |
25,428,856
+872,994
| +4% | +$31.5M | 0.02% | 681 |
|
|
2025
Q1 | $764M | Sell |
24,555,862
-890,658
| -4% | -$27.7M | 0.02% | 753 |
|
|
2024
Q4 | $649M | Buy |
25,446,520
+3,145,361
| +14% | +$80.2M | 0.01% | 909 |
|
|
2024
Q3 | $631M | Sell |
22,301,159
-716,402
| -3% | -$20.3M | 0.01% | 903 |
|
|
2024
Q2 | $607M | Buy |
23,017,561
+1,811,720
| +9% | +$47.8M | 0.01% | 864 |
|
|
2024
Q1 | $644M | Sell |
21,205,841
-253,621
| -1% | -$7.7M | 0.02% | 851 |
|
|
2023
Q4 | $603M | Buy |
21,459,462
+895,608
| +4% | +$25.2M | 0.02% | 860 |
|
|
2023
Q3 | $558M | Sell |
20,563,854
-177,665
| -0.9% | -$4.82M | 0.02% | 822 |
|
|
2023
Q2 | $638M | Buy |
20,741,519
+892,677
| +4% | +$27.4M | 0.02% | 777 |
|
|
2023
Q1 | $715M | Buy |
19,848,842
+435,591
| +2% | +$15.7M | 0.02% | 682 |
|
|
2022
Q4 | $767M | Buy |
19,413,251
+1,143,162
| +6% | +$45.2M | 0.02% | 629 |
|
|
2022
Q3 | $734M | Sell |
18,270,089
-127,551
| -0.7% | -$5.12M | 0.03% | 609 |
|
|
2022
Q2 | $773M | Buy |
18,397,640
+914,452
| +5% | +$38.4M | 0.02% | 610 |
|
|
2022
Q1 | $681M | Buy |
17,483,188
+767,864
| +5% | +$29.9M | 0.02% | 760 |
|
|
2021
Q4 | $666M | Buy |
16,715,324
+1,254,479
| +8% | +$50M | 0.02% | 815 |
|
|
2021
Q3 | $559M | Buy |
15,460,845
+5,173,204
| +50% | +$187M | 0.02% | 895 |
|
|
2021
Q2 | $422M | Sell |
10,287,641
-3,376,940
| -25% | -$138M | 0.01% | 1159 |
|
|
2021
Q1 | $596M | Buy |
13,664,581
+4,611,036
| +51% | +$201M | 0.02% | 856 |
|
|
2020
Q4 | $453M | Buy |
9,053,545
+5,321,913
| +143% | +$266M | 0.01% | 972 |
|
|
2020
Q3 | $157M | Buy |
3,731,632
+1,681,487
| +82% | +$70.7M | 0.01% | 1574 |
|
|
2020
Q2 | $99.5M | Buy |
+2,050,145
| New | +$99.5M | ﹤0.01% | 1834 |
|